Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 15
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Impact of the 2008 economic crisis on the burden of hepatitis B and C diseases in Southern European countries

  • Palladino, Claudia
  • Ramis, Rebeca|||0000-0001-6154-9142
  • Ezeonwumelu, I.J.|||0000-0003-4007-2212
  • Biondi, Antonio
  • Carreras, Giulia|||0000-0002-1427-637X
  • Fischer, Florian
  • Gallus, Silvano|||0000-0002-8967-0400
  • Golinelli, Davide
  • Gorini, Giuseppe|||0000-0002-1413-5948
  • Hassan, Shoaib
  • Kabir, Zubair
  • Koyanagi, Ai|||0000-0002-9565-5004
  • Lazarus, Jeffrey V.|||0000-0001-9618-2299
  • Mentis, Alexios-Fotios A.
  • Meretoja, Tuomo|||0000-0002-2691-0710
  • Mokdad, Ali H.
  • Monasta, Lorenzo|||0000-0001-7774-548X
  • Mulita, Francesk|||0000-0001-7198-2628
  • Postma, Maarten J.
  • Tabarés-Seisdedos, Rafael|||0000-0002-1089-2204
  • Thiyagarajan, Arulmani
  • Taveira, Nuno|||0000-0003-0176-5585
  • Briz, Verónica|||0000-0003-2297-5098
Background: The economic crisis that began in 2008 has severely affected Southern (Greece, Italy, Portugal, Spain) Western European (SWE) countries of Western Europe (WE) and may have affected ongoing efforts to eliminate viral hepatitis. This study was conducted to investigate the impact of the economic crisis on the burden of HBV and HCV disease. Methods: Global Burden of Diseases 2019 data were used to analyse the rates of epidemiological metrics of HBV and HCV acute and chronic infections in SWE and WE. Time series modelling was performed to quantify the impact of healthcare expenditure on the time trend of HBV and HCV disease burden in 2000-2019. Results: Declining trends in incidence and prevalence rates of acute HBV (aHBV) and chronic HBV were observed in SWE and WE, with the pace of decline being slower in the post-austerity period (2010-2019) and mortality due to HBV stabilised in SWE. Acute HCV (aHCV) metrics and chronic HCV incidence and mortality showed a stable trend in SWE and WE, whereas the prevalence of chronic HCV showed an oscillating trend, decreasing in WE in 2010-2019 (p < 0.001). Liver cancer due to both hepatitis infections showed a stagnant burden over time. An inverse association was observed between health expenditure and metrics of both acute and chronic HBV and HCV. Conclusions: Epidemiological metrics for HBV and HCV showed a slower pace of decline in the post-austerity period with better improvement for HBV, a stabilisation of mortality and a stagnant burden for liver cancer due to both hepatitis infections. The economic crisis of 2008 had a negative impact on the burden of hepatitis B and C. Elimination of HBV and HCV by 2030 will be a major challenge in the SWE countries.
Repisalud
Publication Artículo científico (JournalArticle)

IL7RA rs10491434 polymorphism is related to spontaneous HIV infection control in naïve HIV-infected patients: A retrospective study.

  • Sepulveda-Crespo, Daniel
  • Jimenez-Sousa, Maria Angeles
  • Fernandez-Rodriguez, Amanda
  • Muñoz-Fernández, María A
  • Jiménez, José L
  • Caraciolo, Begoña B
  • Reus Bañuls, Sergio
  • Vilchez, Helem
  • Mothe, Beatriz
  • Martinez, Isidoro
  • Benito, José M
  • Rallón, Norma
  • Resino, Salvador
Interleukin 7 receptor (IL7R) is vital in the adaptive immune response against human immunodeficiency viruses (HIV). We assessed IL7RA polymorphisms (SNPs) in antiretroviral therapy (ART)-naïve HIV patients for their association with spontaneous HIV infection control. We conducted a retrospective cohort study involving 667 ART-naïve patients categorized by HIV progression (ordinal variable): 150 rapid progressors, 334 moderate/typical progressors, 86 long-term nonprogressors elite controllers (LTNPs-EC), and 97 LTNPs-non-EC. We genotyped three IL7RA SNPs using Agena Bioscience's MassARRAY platform. The association between IL7RA SNPs and spontaneous HIV infection control was evaluated using ordinal logistic regression. Individuals carrying the rs10491434 G allele have a higher likelihood of spontaneous HIV infection control (adjusted odds ratio [aOR] = 1.33; p = 0.023). Moreover, the IL7RA GCT haplotype, consisting of three specific SNPs (rs6897932, rs987106, and rs10491434), demonstrated an association with the control of untreated HIV infection (aOR = 1.34; p = 0.050). Remarkably, the rs10491434 SNP and the IL7RA GCT haplotype exhibited similar aOR values, suggesting that rs10491434 may be primarily responsible for the observed effect of the haplotype. IL7RA rs10491434 G allele is associated with a higher likelihood of spontaneous HIV infection control, indicating its significant role in the pathogenesis of HIV, possibly influencing infection course and viral replication control.
Repisalud
Publication Artículo científico (JournalArticle)

Extracellular vesicles derived microRNAs as non-invasive markers of liver fibrosis in chronically infected HCV patients: a pilot study.

  • Cairoli, Victoria
  • Valle-Millares, Daniel
  • Ryan, Pablo
  • Dominguez, Lourdes
  • Martín-Carbonero, Luz
  • De Los Santos, Ignacio
  • De Matteo, Elena
  • Ameigeiras, Beatriz
  • De Sousa, Marcela
  • Briz, Veronica
  • Preciado, María V
  • Fernandez-Rodriguez, Amanda
  • Valva, Pamela
Extracellular vesicles (EVs) are an increasingly promising tool for liquid biopsy in liver diseases. Hepatitis C Virus (HCV) infection, alone or together with Human Immunodeficiency Virus (HIV) infection significantly impacts on the microRNA (miRNA) EVs content resembling chronic hepatitis C (CHC) progression. The objective of the study was to delve into the intricate EVs-miRNA profiles in CHC patients with different liver fibrosis stages, aiming to pinpoint non-invasive markers capable of distinguishing significant fibrosis. Plasma EV-miRNAs from 50 CHC patients (HCV+ and HCV+/HIV+) stratified in no significant (F < 2) and significant (F ≥ 2) fibrosis, were massively sequenced. General linear models (GLM) were used to identify significantly differential expressed (SDE) miRNAs according to liver fibrosis stages (F ≥ 2 and F < 2). Dysregulated biological pathways were subsequently analyzed for the following groups: i) all patients; ii) HCV+; and iii) HCV+/HIV+. Multiple-ordered logistic regression analysis was performed to develop a score to identify F ≥ 2 cases. The diagnostic potential of both the SDE miRNAs and the developed score was assessed using ROC curve analysis. With respect to all CHC patients, two SDE miRNAs (hsa-miR-122-5p and hsa-miR-92a-3p) were identified which regulate genes related to cytoskeleton organization. Regarding their diagnostic performance to discriminate F ≥ 2, both miRNAs individually demonstrated acceptable diagnostic values. However, their combined use in a new score enhanced their diagnostic performance (AUROC = 0.833). In the HCV+ subgroup, 8 SDE miRNAs (hsa-miR-122-5p, hsa-miR-320c, hsa-miR-3615, hsa-miR-320a-3p, hsa-miR-374b-5p, hsa-let-7a-3p, hsa-miR-199a-5p, hsa-miR-142-5p), which regulate macrophage activity and cell growth/death regulation, were recognized. Among them, hsa-miR-3615 displayed the highest diagnostic performance to discriminate F ≥ 2 (AUROC = 0.936). With respect to HCV+/HIV+, 18 SDE miRNAs (hsa-miR-4508, hsa-miR-122-5p, hsa-miR-451a, hsa-miR-1290, hsa-miR-1246, hsa-miR-107, hsa-miR-15b-5p, hsa-miR-194-5p, hsa-miR-22-5p, hsa-miR-20b-5p, hsa-miR-142-5p, hsa-miR-328-3p, hsa-miR-335-3p, hsa-miR-125a-5p, hsa-miR-423-3p, hsa-let-7d-3p, hsa-miR-128-3p, hsa-miR-10a-5p) were recognized that regulate RNA silencing processes. In this case, hsa-miR-423-3p and hsa-miR-128-3p showed outstanding diagnostic performances (AUROC > 0.900). Distinct EVs-miRNA profiles were identified in patients with varying liver fibrosis stages, both in the overall CHC cohort and within HCV+ and HCV+/HIV+ subgroups. These specific miRNA signatures would allow the elucidation of potential mechanisms involved in clinical evolution and identification of specific biomarkers of unfavorable progression, plausible to be used in a diagnostic panel. Furthermore, the developed score demonstrates the ability to discriminate within the CHC group those individuals with significant fibrosis regardless of their HIV infection status.
Repisalud
Publication Artículo científico (JournalArticle)

HIV status defines distinct immunological drivers of persistent portal hypertension after HCV cure in people with advanced cirrhosis.

  • Martín-Escolano, Rubén
  • Fernandez-Rodriguez, Amanda
  • Tarancon-Diez, Laura
  • Berenguer, Juan
  • Codina Márquez, Helena
  • Amigot-Sánchez, Rafael
  • González-García, Juan
  • Hontañón, Víctor
  • Pérez-Latorre, Leire
  • Ibañez-Samaniego, Luis
  • Llop-Herrera, Elba
  • Olveira, Antonio
  • Díaz, Laura
  • Martinez, Isidoro
  • Jimenez-Sousa, Maria Angeles
  • Resino, Salvador
Introduction: The immunological drivers of portal hypertension regression after hepatitis C virus (HCV) cure are poorly understood, particularly in the context of human immunodeficiency virus (HIV) coinfection We aimed to identify baseline immune signatures predicting the evolution of the hepatic venous pressure gradient (HVPG) in people with and without HIV (PWH/PWoH). Methods: We prospectively followed 41 individuals with advanced cirrhosis (18 PWoH, 23 PWH) who were cured of HCV with direct-acting antivirals (DAA). Baseline plasma and cellular immune markers were extensively profiled using multiplex assays and flow cytometry. We used mixed-effects modeling to test for associations between these baseline immune features and the change in HVPG over a 48-week follow-up period, with q-values controlling for false discoveries. Results: Two distinct immunological profiles of impaired HVPG regression emerged. In PWoH, impaired regression was linked to a broad proinflammatory profile [TNF-α (AMR = 1.13; q=0.012), IL17A (AMR = 1.28; q=0.012), and IL10 (AMR = 1.2; q=0.028)], a widespread total CD4+ T-cell activation [HLA-DR+ (AMR = 1.44; q<0.001) and CD38+HLA-DR+ (AMR = 1.3; q=0.007)], and robust activation across central memory (CM) and effector memory (EM) subsets. Conversely, in PWH, impaired HVPG regression was associated with sVCAM-1 (AMR = 1.58; q=0.096), and a more focused activation within EM (HLA-DR+, AMR = 1.08; q=0.030) and TemRA (CD38+HLA-DR+, AMR = 1.12; q=0.030) CD4+ T-cells. Discussion: HIV coinfection fundamentally reshapes the immunological landscape of post-cure portal hypertension recovery. The shift from systemic inflammation in PWoH to endothelial dysfunction and T-cell exhaustion in PWH reveals distinct pathological pathways. Understanding these signatures is a crucial step toward developing targeted therapies to promote complete hepatic recovery.
Repisalud
Publication Artículo científico (JournalArticle)

Lipid and immune dysregulation and risk of metabolic disorders after HCV clearance in HIV/HCV-coinfected participants with cACLD: a retrospective study.

  • Virseda-Berdices, Ana
  • Requena, Belen
  • Berenguer, Juan
  • González-García, Juan
  • Gonzalez-Riano, Carolina
  • Díez, Cristina
  • Hontañon, Victor
  • Fernandez-Rodriguez, Amanda
  • Barbas, Coral
  • Resino, Salvador
  • Martín-Escolano, Rubén
  • Jimenez-Sousa, Maria Angeles
Introduction: People with HIV and chronic hepatitis C may develop metabolic complications after sustained virologic response (SVR), possibly due to persistent molecular alterations induced by HCV. This study aimed to identify baseline (pre-treatment) lipid and immune biomarkers associated with post-SVR metabolic events in HIV/HCV-coinfected participants with compensated advanced chronic liver disease (cACLD) receiving long-term suppressive antiretroviral therapy. Methods: We conducted a retrospective study of 56 HIV/HCV-coinfected participants with cACLD. Untargeted lipidomic profiling was performed on baseline plasma samples using a liquid-chromatography-mass spectrometer. The outcome was the development of metabolic events (diabetes mellitus and/or hyperlipidemia) during follow-up, up to seven years post-HCV treatment. Statistical analyses included orthogonal partial least squares discriminant analysis (OPLS-DA), Cox regressions models, and Spearman correlations with inflammation-related biomarkers and immune checkpoint proteins, with multiple comparison corrections using the false discovery rate. Results: 25% participants developed metabolic events after SVR. OPLS-DA identified 163 lipid species (VIP scores≥1) associated with these events, and adjusted Cox regression confirmed significant associations for 24 of them. Lysophosphatidylcholines (LPCs) were the most prevalent, with higher baseline levels linked to increased metabolic risk. Participants who developed events also had higher levels of plasmalogens LPC (O-LPC), lysophosphatidylethanolamine (LPE), lysophosphatidylinositol (LPI), lysophosphatidic acid (LPA), and phosphosphatidylcholine (PC). Several lipid species correlated positively with the pro-inflammatory cytokine IL-18, the anti-inflammatory suppressor IL-1RA, and the immune checkpoint proteins IDO and S100A8/A9. Discussion: Pre-treatment lipid and immune dysregulation was associated with post-SVR metabolic events in HIV/HCV-coinfected participants, suggesting that HCV may leave a lasting metabolic imprint that contributes to adverse outcomes after viral clearance.
Repisalud
Publication Artículo científico (JournalArticle)

IRF5-TNOP3 polymorphisms are associated with elite control of HIV infection: A retrospective study.

  • Sepulveda-Crespo, Daniel
  • Jimenez-Sousa, Maria Angeles
  • Fernandez-Rodriguez, Amanda
  • Muñoz-Fernández, María A
  • Jiménez, José Luis
  • Moreno, Santiago
  • Garcia, Felipe
  • Martinez, Isidoro
  • Benito, José M
  • Rallón, Norma
  • Resino, Salvador
IRF5-TNPO3 polymorphisms have previously been related to immune response, and TNPO3 plays a role in human immunodeficiency virus (HIV)-1 infection after nuclear import. Therefore, we analyzed the genetic association between IRF5-TNPO3 polymorphisms and the HIV elite control in long-term nonprogressors (LTNPs). We performed a retrospective cohort study on 183 LTNPs, who were antiretroviral therapy-naïve with CD4  ≥ 500 cells/mm , viral load ≤10 000 copies/mL, and asymptomatic over 10 years after HIV seroconversion. The primary outcome variable was HIV elite control (undetectable viral load in at least 90% of the measurements for at least 1 year). Seven IRF5-TNPO3 polymorphisms were genotyped using Agena Bioscience's MassARRAY platform. We found a significant association between specific IRF5-TNPO3 genotypes and HIV elite control: rs2004640 TT (aOR = 2.05; p = 0.041), rs10954213 AA (aOR = 1.95; p = 0.035), rs2280714 TT (aOR = 2.02; p = 0.031), and rs10279821 CC (aOR = 2.12; p = 0.017). We also found a significant association between IRF5-TNPO3 haplotype TATC composed of the favorable significant polymorphisms (rs2004640, rs10954213, rs2280714, and rs10279821) and the HIV elite control (aOR = 1.59; p = 0.048). IRF5-TNPO3 rs2004640, rs10954213, rs2280714, and rs10279821 polymorphisms were related to HIV elite control in LTNPs. Our data provide new knowledge about the impact of IRF5-TNPO3 polymorphisms on HIV pathogenesis to understand the phenomenon of natural HIV control.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Different HCV Exposure Drives Specific miRNA Profile in PBMCs of HIV Patients

  • Valle-Millares, Daniel
  • Brochado-Kith, Óscar
  • Martín-Carbonero, Luz
  • Domínguez-Domínguez, Lourdes
  • Ryan, Pablo
  • De Los Santos, Ignacio
  • De la Fuente, Sara
  • Castro, Juan M.
  • Lagarde, María
  • Cuevas, G.
  • Mayoral-Muñoz, Mario
  • Matarranz, Mariano
  • Díez, Victorino
  • Gómez-Sanz, Alicia
  • Martínez-Román, Paula
  • Crespo-Bermejo, Celia
  • Palladino, Claudia
  • Muñoz Muñoz, María
  • Jiménez-Sousa, María Angeles
  • Resino, Salvador
  • Briz, Verónica
  • Fernández-Rodríguez, Amanda
18 Pág. Departamento de ​Mejora Genética Animal, Micro RNAs (miRNAs) are essential players in HIV and HCV infections, as both viruses modulate cellular miRNAs and interact with the miRNA-mediated host response. We aim to analyze the miRNA profile of HIV patients with different exposure to HCV to explore specific signatures in the miRNA profile of PBMCs for each type of infection. We massively sequenced small RNAs of PBMCs from 117 HIV+ infected patients: 45 HIV+ patients chronically infected with HCV (HIV/HCV+), 36 HIV+ that spontaneously clarified HCV after acute infection (HIV/HCV-) and 36 HIV+ patients without previous HCV infection (HIV). Thirty-two healthy patients were used as healthy controls (HC). Differential expression analysis showed significantly differentially expressed (SDE) miRNAs in HIV/HCV+ (n = 153), HIV/HCV- (n = 169) and HIV (n = 153) patients. We found putative dysregulated pathways, such as infectious-related and PI3K signaling pathways, common in all contrasts. Specifically, putatively targeted genes involved in antifolate resistance (HIV/HV+), cancer-related pathways (HIV/HCV-) and HIF-signaling (HIV) were identified, among others. Our findings revealed that HCV strongly influences the expression profile of PBMCs from HIV patients through the disruption of its miRNome. Thus, different HCV exposure can be identified by specific miRNA signatures in PBMCs., This work has been supported by grants from Institute of Health Carlos III, [PI15CIII/00031 and PI18CIII/00020/ to AFR and VB] and the Foundation Universidad Alfonso X el Sabio-Santander [grant number 1.010.932 to AFR] and the Spanish AIDS Research Network (RD16CIII/0002/0002), and Centro de Investigación Biomédica en Red (CIBER) en Enfermedades Infecciosas (CB21/13/00044). AFR is supported by the Miguel Servet programme from Fondo de Investigación Sanitaria (ISCIII) [CP14/CIII/00010 and CPII20CIII/0001], Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Staphylococcus aureus nasal colonization in Spanish children. The COSACO nationwide surveillance study

  • Del Rosal, T.
  • Echevarría, A.M.
  • Garcia-Vera, C.
  • Escosa-Garcia, L.
  • Agud, M.
  • Chaves, F.
  • Román, F.
  • Gutierrez-Fernandez, J.
  • de Gopegui, E.R.
  • Ruiz-Carrascoso, G.
  • Ruiz-Gallego, M.C.
  • Bernet, A.
  • Quevedo, S.M.
  • Fernández-Verdugo, A.M.
  • Díez-Sebastian, J.
  • Calvo, C.
Objective: To assess the prevalence and risk factors for S. aureus and methicillin-resistant S. aureus (MRSA) nasal colonization in Spanish children. Methods: Cross-sectional study of patients <14 years from primary care centers all over Spain. Clinical data and nasal aspirates were collected from March to July 2018. Results: A total of 1876 patients were enrolled. Prevalence of S. aureus and MRSA colonization were 33% (95% CI 30.9–35.1) and 1.44% (95% CI 0.9–2), respectively. Thirtythree percent of the children (633/1876) presented chronic conditions, mainly atopic dermatitis, asthma and/or allergy (524/633). Factors associated with S. aureus colonization were age =5 years (OR 1.10, 95% CI 1.07–1.12), male sex (OR 1.43, 95% CI 1.17–1.76), urban setting (OR 1.46, 95% CI 1.08–1.97) and the presence of asthma, atopic dermatitis or allergies (OR 1.25; 95% CI: 1.093–1.43). Rural residence was the only factor associated with MRSA colonization (OR 3.62, 95% CI 1.57–8.36). MRSA was more frequently resistant than methicillin-susceptible S. aureus to ciprofloxacin [41.2% vs 2.6%; p<0.0001], clindamycin [26% vs 16.9%; p=0.39], and mupirocin [14.3% vs 6.7%; p=0.18]. None of the MRSA strains was resistant to tetracycline, fosfomycin, vancomycin or daptomycin. Conclusions: The main risk factors for S. aureus colonization in Spanish children are being above five years of age, male gender, atopic dermatitis, asthma or allergy, and residence in urban areas. MRSA colonization is low, but higher than in other European countries and is associated with rural settings.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Characterization of methicillin-resistant Staphylococcus aureus strains colonizing the nostrils of Spanish children

  • Román, F.
  • Mendez-Echevarria, A.
  • Del Rosal, T.
  • Garcia-Vera, C.
  • Escosa-Garcia, L.
  • Agud, M.
  • Chaves, F.
  • Gutiérrez-Fernández, J.
  • Ruiz de Gopegui, E.
  • Ruiz-Carrascoso, G.
  • Ruiz-Gallego, M. C.
  • Bernet A.
  • Quevedo S. M.
  • Fernández-Verdugo, A. M.
  • Sainz, T.
  • Calvo, C.
Objective: To characterize the Staphylococcus aureus strains colonizing healthy Spanish children. Methods: Between March and July 2018, 1876 Spanish children younger than 14 years attending primary healthcare centers were recruited from rural and urban areas. Staphylococcus aureus colonization of the anterior nostrils was analyzed. MecA and mecC genes, antibiotic susceptibility, and genotyping according to the spa were determined in all strains, and the following toxins were examined: Panton-Valentine leucocidin (pvl), toxic shock syndrome toxin (tst), and exfoliative toxins (eta, etb, etd). Multilocus sequence typing (MLST) and staphylococcal cassette chromosome (SCCmec) typing were performed on methicillin-resistant Staphylococcus aureus (MRSA) strains, as well as pulsed-field gel electrophoresis (PFGE). Results: 619 strains were isolated in 1876 children (33%), and 92% of them were sent for characterization to the Spanish National Centre of Microbiology (n = 572). Twenty (3.5%) of these strains were mecA-positive. Several spa types were detected among MRSA, being t002 the most frequently observed (30%), associating with SCCmec IVc. Among MSSA, 33% were positive for tst, while only 0.73% were positive for pvl. The 20 MRSA strains were negative for pvl, and 6 (30%) harbored the tst gene. Conclusions: methicillin-resistant Staphylococcus aureus nasal colonization in Spanish children is rare, with t002 being the most observed spa type, associated with SCCmec IVc. None of the MRSA strains produced pvl, but up to 30% of S. aureus strains were positive for tst.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3

  • Sola-Campoy, Pedro Juan
  • Delgado-Valverde, Mercedes
  • Cano, María E.
  • Gijón, Desirèe
  • Larrosa Escartin, María Nieves
  • Gonzalez Lopez, Juan Jose
  • Cañada-Garcia, Javier E.
  • Moure Garcia, Zaira
Carbapenemases; High-risk clones; Whole genome sequencing, Carbapenemasas; Clones de alto riesgo; Secuenciación del genoma completo, Carbapenemases; Clons d'alt risc; Seqüenciació del genoma sencer, Objectives: CARB-ES-19 is a comprehensive, multicenter, nationwide study integrating whole-genome sequencing (WGS) in the surveillance of carbapenemase-producing K. pneumoniae (CP-Kpn) and E. coli (CP-Eco) to determine their incidence, geographical distribution, phylogeny, and resistance mechanisms in Spain. Methods: In total, 71 hospitals, representing all 50 Spanish provinces, collected the first 10 isolates per hospital (February to May 2019); CPE isolates were first identified according to EUCAST (meropenem MIC > 0.12 mg/L with immunochromatography, colorimetric tests, carbapenem inactivation, or carbapenem hydrolysis with MALDI-TOF). Prevalence and incidence were calculated according to population denominators. Antibiotic susceptibility testing was performed using the microdilution method (EUCAST). All 403 isolates collected were sequenced for high-resolution single-nucleotide polymorphism (SNP) typing, core genome multilocus sequence typing (cgMLST), and resistome analysis. Results: In total, 377 (93.5%) CP-Kpn and 26 (6.5%) CP-Eco isolates were collected from 62 (87.3%) hospitals in 46 (92%) provinces. CP-Kpn was more prevalent in the blood (5.8%, 50/853) than in the urine (1.4%, 201/14,464). The cumulative incidence for both CP-Kpn and CP-Eco was 0.05 per 100 admitted patients. The main carbapenemase genes identified in CP-Kpn were blaOXA–48 (263/377), blaKPC–3 (62/377), blaVIM–1 (28/377), and blaNDM–1 (12/377). All isolates were susceptible to at least two antibiotics. Interregional dissemination of eight high-risk CP-Kpn clones was detected, mainly ST307/OXA-48 (16.4%), ST11/OXA-48 (16.4%), and ST512-ST258/KPC (13.8%). ST512/KPC and ST15/OXA-48 were the most frequent bacteremia-causative clones. The average number of acquired resistance genes was higher in CP-Kpn (7.9) than in CP-Eco (5.5). Conclusion: This study serves as a first step toward WGS integration in the surveillance of carbapenemase-producing Enterobacterales in Spain. We detected important epidemiological changes, including increased CP-Kpn and CP-Eco prevalence and incidence compared to previous studies, wide interregional dissemination, and increased dissemination of high-risk clones, such as ST307/OXA-48 and ST512/KPC-3., This research was supported by grants from the Instituto de Salud Carlos III (numbers PI18CIII/00030 and PI21CIII/00039). It was also supported by Plan Nacional de I + D + i 2013–2016, Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (grants RD16CIII/0004/0002, RD16/0016/0001, RD16/0016/0003, RD16/0016/0004, RD16/0016/0006, RD16/0016/0007, RD16/0016/0008, RD16/0016/0010, and RD16/0016/0011). Cofinanced by the European Development Regional Fund “A way to achieve Europe,” Operative Program Intelligent Growth 2014–2020. CIBER – Consorcio Centro de Investigación Biomédica en Red (CB21/13/00095, CB21/13/00012, CB21/13/00049, CB21/13/00054, CB21/13/00055, CB21/13/00068, CB21/13/00081, CB21/13/00084, and CB21/13/00099) (CIBERINFEC) and Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea – NextGenerationEU also supported this work.
Docta Complutense
Publication Artículo científico (JournalArticle)

Low-level HIV-1 viremia affects T-cell activation and senescence in long-term treated adults in the INSTI era

  • Lara Aguilar, Violeta
  • Llamas Adán, Manuel
  • Brochado Kith, Óscar
  • Crespo Bermejo, Celia
  • Grande García, Sergio
  • Arca Lafuente, Sonia
  • De los Santos, Ignacio
  • Prado, Carmen
  • Alía, Mario
  • Sainz Pinós, Coral
  • Fernández Rodríguez, Amanda
  • Martín Carbonero, Luz
  • Madrid González, Ricardo
  • Briz, Verónica
Background Around 10% of people with HIV (PWH) exhibit a low-level viremia (LLV) under antiretroviral therapy (ART). However, its origin and clinical significance are largely unknown, particularly at viremias between 50 and 200 copies/mL and under modern ART based on integrase strand transfer inhibitors (INSTIs). Our aim was to characterize their poor immune response against HIV in comparison to individuals with suppressed viremia (SV) and non-HIV controls (NHC). Methods Transversal observational study in 81 matched participants: 27 PWH with LLV, 27 PWH with SV, and 27 NHC. Activation (CD25, HLA-DR, and CD38) and senescence [CD57, PD1, and HAVCR2 (TIM3)] were characterized in peripheral T-cell subsets by spectral flow cytometry. 45 soluble biomarkers of systemic inflammation were evaluated by immunoassays. Differences in cell frequencies and plasma biomarkers among groups were evaluated by a generalized additive model for location, scale, and shape (GAMLSS) and generalized linear model (GLM) respectively, adjusted by age, sex at birth, and ART regimen.</jats:p> Results The median age was 53 years and 77.8% were male. Compared to NHC, PWH showed a lower CD4+/CD8+ ratio and increased activation, senescence, and inflammation, highlighting IL-13 in LLV. In addition, LLV showed a downtrend in the frequency of CD8+ naive and effector memory (EM) type 1 compared to SV, along with higher activation and senescence in CD4+ and CD8+ EM and terminally differentiated effector memory RA+ (TEMRA) subpopulations. No significant differences in systemic inflammation were observed between PWH groups. Conclusion LLV between 50 and 200 copies/mL leads to reduced cytotoxic activity and T-cell dysfunction that could affect cytokine production, being unable to control and eliminate infected cells. The increase in senescence markers suggests a progressive loss of immunological memory and a reduction in the proliferative capacity of immune cells. This accelerated immune aging could lead to an increased risk of developing future comorbidities. These findings strongly advocate for heightened surveillance of these PWH to promptly identify potential future complications.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients

  • Brochado Kith, Óscar|||0000-0001-8372-2604
  • Martínez, Isidoro|||0000-0002-9949-9264
  • Berenguer, Juan|||0000-0001-8541-8200
  • Medrano, Luz María|||0000-0003-3717-5384
  • González García, Juan|||0000-0002-3652-002X
  • Jiménez-Sousa, María Ángeles|||0000-0002-1945-6169
  • Carrero, Ana
  • Hontañón Antoñana, Víctor|||0000-0003-3070-2647
  • Navarro, Jordi|||0000-0002-7187-0367
  • Guardiola Tey, Jose Maria|||0000-0001-5537-2600
  • Fernández-Rodríguez, Amanda|||0000-0002-5110-2213
  • Resino, Salvador|||0000-0001-8783-0450
Objective: To evaluate the impact of hepatitis C virus (HCV) elimination via interferon (IFN)-based therapy on gene expression profiles related to the immune system in HIV/HCV-coinfected patients. Methods: We conducted a prospective study in 28 HIV/HCV-coinfected patients receiving IFN-based therapy at baseline (HIV/HCV-b) and week 24 after sustained virological response (HIV/HCV-f). Twenty-seven HIV-monoinfected patients (HIV-mono) were included as a control. RNA-seq analysis was performed on peripheral blood mononuclear cells (PBMCs). Genes with a fold-change (FC) ≥ 1.5 (in either direction) and false discovery rate (FDR) ≤ 0.05 were identified as significantly differentially expressed (SDE). Results: HIV/HCV-b showed six SDE genes compared to HIV-mono group, but no significantly enriched pathways were observed. For HIV/HCV-f vs. HIV/HCV-b, we found 58 SDE genes, 34 upregulated and 24 downregulated in the HIV/HCV-f group. Of these, the most overexpressed were CXCL2, PDCD6IP, ATP5B, IGSF9, RAB26, and CSRNP1, and the most downregulated were IFI44 and IFI44L. These 58 SDE genes revealed two significantly enriched pathways (FDR < 0.05), one linked to Epstein-Barr virus infection and another related to p53 signaling. For HIV/HCV-f vs. HIV-mono group, we found 44 SDE genes that revealed 31 enriched pathways (FDR < 0.05) related to inflammation, cancer/cell cycle alteration, viral and bacterial infection, and comorbidities associated with HIV/HCV-coinfection. Five genes were overrepresented in most pathways (JUN, NFKBIA, PIK3R2, CDC42, and STAT3). Conclusion: HIV/HCV-coinfected patients who eradicated hepatitis C with IFN-based therapy showed profound gene expression changes after achieving sustained virological response. The altered pathways were related to inflammation and liver-related complications, such as non-alcoholic fatty liver disease and hepatocellular carcinoma, underscoring the need for active surveillance for these patients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3

  • Cañada-García, Javier E.
  • Moure García, Zaira
  • Sola-Campoy, Pedro J.
  • Delgado-Valverde, Mercedes
  • Cano, María E.
  • Gijón, Desirèe
  • González, Mónica
  • Gracia-Ahufinger, Irene
  • Larrosa, María Nieves|||0000-0001-8808-0233
  • Mulet, Xavier
  • Pitart, Cristina|||0000-0002-3083-7915
  • Rivera, Alba|||0000-0002-9709-6162
  • Bou, German|||0000-0001-8837-0062
  • Calvo, Jorge
  • Cantón, Rafael|||0000-0003-1675-3173
  • González-López, Juanjo|||0000-0003-2419-5909
  • Martínez-Martínez, Luis
  • Navarro Risueño, Ferran|||0000-0002-4302-2838
  • Oliver, Antonio|||0000-0001-9327-1894
  • Palacios-Baena, Zaira R.|||0000-0002-1713-6807
  • Pascual Hernández, Álvaro|||0000-0002-8672-5891
  • Ruiz-Carrascoso, Guillermo
  • Vila Estapé, Jordi|||0000-0002-8025-3926
  • Aracil, Belén
  • Pérez-Vázquez, María
  • Oteo-Iglesias, Jesús|||0000-0003-3327-8263
Objectives: CARB-ES-19 is a comprehensive, multicenter, nationwide study integrating whole-genome sequencing (WGS) in the surveillance of carbapenemase-producing K. pneumoniae (CP-Kpn) and E. coli (CP-Eco) to determine their incidence, geographical distribution, phylogeny, and resistance mechanisms in Spain. Methods: In total, 71 hospitals, representing all 50 Spanish provinces, collected the first 10 isolates per hospital (February to May 2019); CPE isolates were first identified according to EUCAST (meropenem MIC.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Discovering HIV related information by means of association rules and machine learning

  • Araujo, Lourdes
  • Martinez-Romo, Juan
  • Bisbal, Otilia|||0000-0003-3746-3378
  • Sánchez-de-Madariaga, Ricardo|||0000-0002-6151-3673
  • Portilla, Joaquín|||0000-0002-3676-9511
  • Portilla, Irene
  • Merino, Esperanza
  • García, Gema
  • Agea, Iván
  • Sánchez Payá, José
  • Rodríguez, Juan Carlos
  • Giner, Livia|||0000-0002-1885-3736
  • Reus, Sergio|||0000-0002-3320-9754
  • Boix, Vicente|||0000-0002-7015-3948
  • Torrus, Diego
  • Pérez, Verónica
  • Portilla, Julia
  • Gómez, Juan Luis
  • Hernández, Jehovana
  • López Lirola, Ana
  • García, Dácil
  • Díaz-Flores, Felicitas
  • Alonso, M. Mar
  • Pelazas, Ricardo
  • Alemán, María Remedios
  • Asensi, Víctor
  • Rivas Carmenado, María Eugenia
  • Suarez-Zarracina, Tomás
  • Pulido, Federico|||0000-0002-7414-8812
  • Rubio, Rafael
  • Hernando, M. Asunción
  • Rial, David
  • de Lagarde, María
  • Arce, Octavio
  • Pinto, Adriana
  • Bermejo, Laura
  • Santacreu, Mireia
  • Navarro, Roser
  • Gonzalez, Candela
  • Iribarren, José Antonio
  • Aramburu, M. José
  • Camino, Xabier
  • Von Wichmann, Miguel Ángel
  • Goenaga, Miguel Ángel
  • Bustinduy, M. Jesús
  • Azkune, Harkaitz
  • Ibarguren, Maialen
  • Kortajarena, Xabier
  • Álvarez-Rodriguez, Ignacio
  • Gil, Leire
  • Martínez, Lourdes
  • Gutiérrez, Félix|||0000-0002-9485-6867
  • Robledano, Catalina
  • Masiá, Mar|||0000-0001-9878-2458
  • Padilla Urrea, Sergio|||0000-0002-8420-7310
  • Adsuar, Araceli
  • Pascual, Rafael
  • Fernández, Marta
  • Galiana, Antonio
  • García, José Alberto
  • Barber, Xavier|||0000-0003-3079-5855
  • Agullo, Vanessa
  • García Abellán, Javier
  • Pascual, Reyes
  • Telenti, Guillermo
  • Guillén, Lucía
  • Botella, Ángela
  • Muga, Roberto|||0000-0001-6301-431X
  • Sanvisens, Arantza|||0000-0001-6269-5491
  • Fuster, Daniel|||0000-0003-1262-5860
  • Berenguer, Juan|||0000-0001-8541-8200
  • Gutiérrez, Isabel
  • López, Juan Carlos
  • Ramírez, Margarita
  • Padilla Ortega, Belén
  • Gijon, Paloma|||0000-0002-5011-1927
  • Aldámiz-Echevarría Lois, Maria Teresa|||0000-0002-4374-6940
  • Tejerina, Francisco|||0000-0002-4136-3575
  • Diez, Cristina
  • Pérez Latorre, Leire|||0000-0001-9919-3778
  • Fanciulli, Chiara|||0000-0003-2175-9027
  • Corral, Saray
  • Vidal, Francesc|||0000-0002-6692-6186
  • Martí, Anna
  • Peraire, Joaquín
  • Viladés, Consuelo|||0000-0002-2991-9593
  • Vargas Laguna, Montserrat|||0000-0001-7650-0587
  • Olona, Montserrat|||0000-0001-5303-9361
  • Rull, Anna|||0000-0002-8907-7754
  • Alba, Verónica|||0000-0002-5925-9573
  • Yeregui, Elena|||0000-0003-2994-4219
  • Masip, Jenifer|||0000-0002-9233-5195
  • García-Pardo, Graciano|||0000-0003-0274-6001
  • Gómez Bertomeu, Frederic
  • Espineira, Sonia
  • Montero, Marta|||0000-0002-3432-5394
  • Cuéllar, Sandra
  • Blanes, Marino
  • Tasias, María
  • Calabuig, Eva|||0000-0002-0177-0037
  • Salavert, Miguel|||0000-0002-8571-2124
  • Fernández, Juan
  • Segarra, Inmaculada
  • González García, Juan|||0000-0002-3652-002X
  • Delgado Hierro, Ana
  • Arribas, José Ramón
  • Arribas, Víctor
  • Bernardino, José Ignacio|||0000-0003-3501-8529
  • Busca, Carmen
  • Cano, Joanna
  • Cardiñanos, Julen
  • Castro, Juan Miguel
  • Escosa García, Luis|||0000-0003-0730-4026
  • Falces Romero, Iker|||0000-0001-5888-7706
  • Herranz Pinto, Pedro|||0000-0002-9840-6628
  • Hontañón Antoñana, Víctor|||0000-0003-3070-2647
  • García López-Hortelano, Milagros
  • González Baeza, Alicia
  • Martín Carbonero, Luz|||0000-0001-8102-4079
  • Mayoral, Mario
  • Mellado Peña, María José|||0000-0003-2251-9666
  • Micán-Rivera, R.|||0000-0002-6626-4266
  • Miguel, Rosa de
  • Montejano Sanchez, Rocio|||0000-0002-3446-0545
  • Montes, María Luisa|||0000-0003-1748-813X
  • Moreno, Victoria
  • Ramos, Luis
  • Rodés, Berta
  • Sainz, Talia|||0000-0002-5301-0945
  • Sendagorta, Elena
  • Valencia, Eulalia|||0000-0001-6902-0120
  • Blanco, José Ramón|||0000-0002-4268-0150
  • Pérez-Martínez, Laura|||0000-0002-1384-024X
  • Oteo, José A.|||0000-0001-7080-6542
  • Ibarra, Valvanera
  • Metola, Luis
  • Sanz, Mercedes
  • Arazo, Piedad
  • Sampériz, Gloria|||0000-0003-0693-2266
  • Dalmau, David|||0000-0003-1936-478X
  • Martinez, Marina
  • Jaén, Àngels
  • Sanmartí, Montse
  • Cairó, Mireia|||0000-0003-2386-2765
  • Martinez-Lacasa, Javier
  • Velli, Pablo
  • Font, Roser
  • Xercavins, M.|||0000-0003-1463-6344
  • Alonso, Noemí
  • Aiello, Tommaso Francesco|||0000-0003-4441-6318
  • Rivero, María
  • Piérola, Beatriz
  • Goikoetxea, Maider
  • Gracia, María
  • Ibero, Carlos
  • Moreno, Estela
  • Repáraz, Jesús
  • Navarro Rubio, Gemma|||0000-0002-7195-9046
  • Cervantes Garcia, Manuel|||0000-0001-6073-1110
  • Calzado, Sonia|||0000-0002-2975-6448
  • Navarro Vilasaro, Marta|||0000-0002-3784-4405
  • López Garcia, Belen
  • de los Santos Gil, Ignacio|||0000-0001-7073-5211
  • de los Santos, Alejandro
  • Sanz, Jesús
  • García-Fraile Fraile, Lucio|||0000-0002-2512-6107
  • Martín, Enrique
  • Sánchez Cerrillo, Ildefonso
  • Calvet-Mirabent, Marta|||0000-0002-9134-0849
  • Barrios, Ana
  • Bautista, Azucena
  • Sáez, Carmen
  • Ciudad, Marianela
  • Gutiérrez, Ángela
  • Moreno, Santiago|||0000-0002-2843-1094
  • del Campo, Santos|||0000-0003-2234-5432
  • Casado, José Luis|||0000-0002-7639-8591
  • Dronda, Fernando|||0000-0002-0443-5816
  • Moreno, Ana
  • Pérez Elías, Mª Jesus|||0000-0001-5700-5257
  • Serrano-Villar, Sergio|||0000-0002-5447-3554
  • Vivancos-Gallego, María J.|||0000-0002-9373-6011
  • Martínez Sanz, Javier|||0000-0003-2020-3908
  • Vallejo, Alejandro
  • Sanchez, Matilde
  • Pérez-Molina, José Antonio
  • Hermida, José Manuel
  • Bernal, Enrique|||0000-0002-4041-0579
  • Alcaraz, Antonia
  • Bravo Urbieta, Joaquín|||0000-0003-2079-0305
  • Muñoz, Ángeles
  • Tomás, Cristina
  • Martínez, Mónica
  • Villalba, M. Carmen
  • García, Federico
  • Martínez, Clara
  • Hernández, José
  • Muñoz Medina, Leopoldo|||0000-0001-8995-8271
  • Álvarez, Marta
  • Chueca, Natalia|||0000-0002-3420-3290
  • Vinuesa, David|||0000-0002-5663-8447
  • de Salazar, Adolfo|||0000-0002-4318-858X
  • Fuentes, Ana
  • Guirao, Emilio
  • Viñuela, Laura
  • Ruiz-Sancho, Andrés
  • Anguita, Francisco
  • Del Romero Guerrero, Jorge|||0000-0001-8922-5182
  • Raposo, Montserrat
  • Rodríguez, Carmen
  • Puerta, Teresa
  • Carrió, Juan Carlos
  • Vera, Mar|||0000-0002-3841-7747
  • Ballesteros, Juan
  • Ayerdi, Oskar|||0000-0002-9441-8031
  • Baza, Begoña
  • Orviz, Eva|||0000-0002-2684-3431
  • Antela, Antonio
  • Losada, Elena
  • Riera, Melchor
  • Peñaranda, María|||0000-0001-6290-3457
  • Ribas, Maria Àngels
  • Campins, Antoni A.
  • Garcia-Gazalla, Mercedes
  • Fanjul, Francisco J.
  • Murillas, Javier|||0000-0003-2169-7110
  • Homar, Francisco|||0000-0003-0116-3277
  • Vilchez, Helem H.
  • Martin, Luisa
  • Payeras, Antoni
  • Santos, Jesús
  • López, María
  • Gómez, Cristina
  • Viciana, Isabel
  • Palacios, Rosario
  • López Cortés, Luis Fernando|||0000-0002-3804-3458
  • Espinosa, Nuria|||0000-0003-2249-2352
  • Roca, Cristina
  • Llaves, Silvia
  • Tiraboschi, Juan Manuel|||0000-0002-0073-873X
  • Imaz, Arkaitz|||0000-0001-8411-1952
  • Silva, Ana Karina
  • Saumoy, Maria|||0000-0002-0047-1991
  • Scévola, Sofia|||0000-0003-3578-5031
  • Curran, Adrian|||0000-0002-1263-0814
  • Falcó, Vicenç|||0000-0001-9626-0023
  • Navarro, Jordi|||0000-0002-7187-0367
  • Burgos, Joaquín|||0000-0001-8445-3047
  • Suanzes, Paula|||0000-0002-6871-0098
  • García, Jorge
  • Descalzo Jorro, Vicente
  • Álvarez, Patricia
  • Planas, Bibiana|||0000-0002-1490-7127
  • Sanchiz Cruz, Marta|||0000-0002-6727-428X
  • Rodríguez, Lucía
  • Olalla, Julián
  • Sánchez, M. José
  • Pérez, Javier
  • del Arco, Alfonso
  • de la Torre Lima, Javier|||0000-0003-4718-0320
  • Prada, José Luis
  • Martínez, Onofre J.
  • Martinez, Lorena
  • Vera, Francisco Jesús
  • García, Josefina
  • Alcaraz, Begoña
  • Sánchez Guirao, Antonio Jesús
  • Mena, Álvaro
  • Castro, Ángeles
  • Pernas, Berta
  • Vázquez, Pilar
  • López, Soledad
  • Ibarra, Sofía
  • García, Guillermo
  • Mirena, Josu
  • Ferrero, Óscar Luis
  • López, Josefina
  • Cámara López, Maria Mar
  • De La Peña, Mireia
  • Lopez, Miriam
  • Lopez, Iñigo
  • Lombide, Itxaso
  • Polo, Víctor
  • de Miguel, Joana
  • Galera, Carlos
  • Fernández, Marian
  • Albendin, Helena
  • Castillo, Antonia
  • Iborra, Asunción
  • Moreno, Antonio
  • Merlos, M. Angustias
  • Vidal, Asunción
  • Amador, Concha|||0000-0003-0843-8624
  • Pasquau, Francisco
  • Gil, Concepción
  • Algado, Jose Tomás
  • Suárez-García, Inés|||0000-0002-7016-716X
  • Malmierca Corral, Eduardo|||0000-0002-4071-7247
  • González-Ruano, Patricia|||0000-0003-0395-7740
  • Ruiz, M. Pilar
  • Pascual, José Francisco
  • Sáez, Elena
  • Balsalobre, Luz
  • Villa López, M.
  • Omar, Mohamed
  • Herrero, Carmen|||0000-0002-1392-4224
  • Gómez, M. Amparo
  • De Zarraga, Miguel Alberto
  • Pérez, Desiré
  • Estrada, Vicente|||0000-0002-7795-5986
  • Sanz, Nieves
  • Cabello, Noemí
  • Vergas García, Jorge
  • Núñez, María José
  • Sagastagoitia, Iñigo
  • Górgolas, Miguel
  • Cabello-Ubeda, Alfonso|||0000-0001-8429-8358
  • Álvarez, Beatriz
  • Prieto, Laura
  • Carrillo Acosta, Irene
  • Sanz, José
  • Arranz, Alberto
  • Hernández Gutiérrez, Cristina
  • Novella Mena, María
  • Galindo Puerto, María José
  • Ferrer, Ana Maria|||0000-0002-3381-9472
  • Rivero Román, Antonio|||0000-0002-8643-4250
  • Ruíz, Inma
  • Rivero-Juarez, Antonio|||0000-0002-5813-6889
  • López, Pedro
  • Machuca, Isabel
  • Frias, Mario
  • Camacho, Ángela
  • Pérez, Ignacio
  • Corona, Diana
  • Cervero Jiménez, Miguel|||0000-0001-9387-7917
  • Torres, Rafael
  • Pineda, Juan Antonio
  • Rincón, Pilar
  • Macías, Juan|||0000-0002-4778-790X
  • Real, Luis M.|||0000-0003-4932-7429
  • Corma Gómez, Anaïs|||0000-0002-1078-0237
  • Gonzalez-Serna, Alejandro|||0000-0002-0239-8417
  • Poveda, Eva|||0000-0003-4835-9875
  • Pérez González, Alexandre|||0000-0003-4836-6768
  • Morano, Luis
  • Miralles, Celia
  • Ocampo Hermida, Antonio|||0000-0002-3176-9758
  • Pousada, Guillermo|||0000-0002-2466-8094
  • Patiño, Lucía
  • Dueñas, Carlos
  • Gutiérrez, Sara
  • Tapia, Elena
  • Novoa, Cristina
  • Egües, Xjoylin
  • Telleria, Pablo
Acquired immunodeficiency syndrome (AIDS) is still one of the main health problems worldwide. It is therefore essential to keep making progress in improving the prognosis and quality of life of affected patients. One way to advance along this pathway is to uncover connections between other disorders associated with HIV/AIDS-so that they can be anticipated and possibly mitigated. We propose to achieve this by using Association Rules (ARs). They allow us to represent the dependencies between a number of diseases and other specific diseases. However, classical techniques systematically generate every AR meeting some minimal conditions on data frequency, hence generating a vast amount of uninteresting ARs, which need to be filtered out. The lack of manually annotated ARs has favored unsupervised filtering, even though they produce limited results. In this paper, we propose a semi-supervised system, able to identify relevant ARs among HIV-related diseases with a minimal amount of annotated training data. Our system has been able to extract a good number of relationships between HIV-related diseases that have been previously detected in the literature but are scattered and are often little known. Furthermore, a number of plausible new relationships have shown up which deserve further investigation by qualified medical experts.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3

  • Sola-Campoy, Pedro Juan
  • Delgado-Valverde, Mercedes
  • Cano, María E.
  • Gijón, Desirèe
  • Larrosa Escartin, María Nieves
  • Gonzalez Lopez, Juan Jose
  • Cañada-Garcia, Javier E.
  • Moure Garcia, Zaira
Carbapenemases; High-risk clones; Whole genome sequencing, Carbapenemasas; Clones de alto riesgo; Secuenciación del genoma completo, Carbapenemases; Clons d'alt risc; Seqüenciació del genoma sencer, Objectives: CARB-ES-19 is a comprehensive, multicenter, nationwide study integrating whole-genome sequencing (WGS) in the surveillance of carbapenemase-producing K. pneumoniae (CP-Kpn) and E. coli (CP-Eco) to determine their incidence, geographical distribution, phylogeny, and resistance mechanisms in Spain. Methods: In total, 71 hospitals, representing all 50 Spanish provinces, collected the first 10 isolates per hospital (February to May 2019); CPE isolates were first identified according to EUCAST (meropenem MIC > 0.12 mg/L with immunochromatography, colorimetric tests, carbapenem inactivation, or carbapenem hydrolysis with MALDI-TOF). Prevalence and incidence were calculated according to population denominators. Antibiotic susceptibility testing was performed using the microdilution method (EUCAST). All 403 isolates collected were sequenced for high-resolution single-nucleotide polymorphism (SNP) typing, core genome multilocus sequence typing (cgMLST), and resistome analysis. Results: In total, 377 (93.5%) CP-Kpn and 26 (6.5%) CP-Eco isolates were collected from 62 (87.3%) hospitals in 46 (92%) provinces. CP-Kpn was more prevalent in the blood (5.8%, 50/853) than in the urine (1.4%, 201/14,464). The cumulative incidence for both CP-Kpn and CP-Eco was 0.05 per 100 admitted patients. The main carbapenemase genes identified in CP-Kpn were blaOXA–48 (263/377), blaKPC–3 (62/377), blaVIM–1 (28/377), and blaNDM–1 (12/377). All isolates were susceptible to at least two antibiotics. Interregional dissemination of eight high-risk CP-Kpn clones was detected, mainly ST307/OXA-48 (16.4%), ST11/OXA-48 (16.4%), and ST512-ST258/KPC (13.8%). ST512/KPC and ST15/OXA-48 were the most frequent bacteremia-causative clones. The average number of acquired resistance genes was higher in CP-Kpn (7.9) than in CP-Eco (5.5). Conclusion: This study serves as a first step toward WGS integration in the surveillance of carbapenemase-producing Enterobacterales in Spain. We detected important epidemiological changes, including increased CP-Kpn and CP-Eco prevalence and incidence compared to previous studies, wide interregional dissemination, and increased dissemination of high-risk clones, such as ST307/OXA-48 and ST512/KPC-3., This research was supported by grants from the Instituto de Salud Carlos III (numbers PI18CIII/00030 and PI21CIII/00039). It was also supported by Plan Nacional de I + D + i 2013–2016, Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (grants RD16CIII/0004/0002, RD16/0016/0001, RD16/0016/0003, RD16/0016/0004, RD16/0016/0006, RD16/0016/0007, RD16/0016/0008, RD16/0016/0010, and RD16/0016/0011). Cofinanced by the European Development Regional Fund “A way to achieve Europe,” Operative Program Intelligent Growth 2014–2020. CIBER – Consorcio Centro de Investigación Biomédica en Red (CB21/13/00095, CB21/13/00012, CB21/13/00049, CB21/13/00054, CB21/13/00055, CB21/13/00068, CB21/13/00081, CB21/13/00084, and CB21/13/00099) (CIBERINFEC) and Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea – NextGenerationEU also supported this work.